EMERGENCE OF BEDAQUILINE RESISTANCE AFTER COMPLETION OF BEDAQUILINE-BASED DRUGRESISTANT TB TREATMENT: A CASE STUDY FROM SOUTH AFRICA
.
Guardado en:
Autores principales: | M. de Vos, S. Ley, B. Derendinger, A. Dippenaar, M. Grobbelaar, A. Reuter, J. Daniels, S. Burns, G. Theron, J. Posey, R. Warren, H. Cox |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b576d5e7b4694cc8bf7aa2fe3ed85af0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
IN VITRO ACTIVITY OF BEDAQUILINE AGAINST NON-TUBERCULOUS MYCOBACTERIA
por: I. Torres Godino, et al.
Publicado: (2018) -
Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis
por: Jared S. Mackenzie, et al.
Publicado: (2020) -
Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid
por: Paula J. Gómez-González, et al.
Publicado: (2021) -
Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis
por: Nabila Ismail, PhD, et al.
Publicado: (2021) -
Economic evaluation protocol of a short, all-oral bedaquiline-containing regimen for the treatment of rifampicin-resistant tuberculosis from the STREAM trial
por: Bruce Kirenga, et al.
Publicado: (2020)